Arabic Arabic English English French French German German
dark

Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors

Ripple Therapeutics Corporation a clinical stage, ophthalmology-focused developer of novel pharmaceuticals, is pleased to announce the appointment of Jonathan Talamo, M.D., to the Board of Directors. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Documentary Exposes the Alarming Truth — TV Puts Us In Hypnotic State and Suppresses Critical Thinking

Next Post

Standard Bariatrics® Titan SGS Stapling Technology for Sleeve Gastrectomy Receives FDA Clearance

Related Posts
Total
0
Share